GBI Research, leading business intelligence provider has released its latest report, “Cloud Computing in Pharmaceutical Research and Development - Virtualization of Data through the Cloud Optimizes Next-Generation DNA Sequencing and Clinical Trials Data Management”, which provides insights into the key applications of cloud computing in the research, development and sales effectiveness within the pharmaceutical industry. The report provides an understanding of technological concepts in cloud computing, including cloud computing service models, deployment models and key stakeholders. Information on the major players in the cloud computing space is followed by an overall assessment of the technology in terms of benefits and restraints. Applications of cloud computing in the pharmaceutical industry are explained in the next section, with a focus on next-generation sequencing, bioinformatics, transfer of information across the sales force and clinical trials data management.
Get your copy of this report @ http://www.reportsnreports.com/reports/187719-cloud-computing-in-pharmaceutical-research-and-development-virtualization-of-data-through-the-cloud-optimizes-next-generation-dna-sequencing-and-clinical-trials-data-management.html
Report Details:
Published: August 2012
No. of Pages: 39
Price: Single User License:US$ 3500 Corporate User License:US$10500
GBI Research analyses reveals that cloud computing has managed to change the invention, development, deployment updating and maintenance of information technology (IT) services. While the per-unit cost of computing has decreased due to the exponential increase in the power of modern machines, the cost of managing IT infrastructure has increased over the same time period. This is mainly due to the penetration of systems within the organization which has significantly increased the complexity of the entire infrastructure. Cloud computing promises to deliver existing as well as new functionalities of IT, coupled with a significant reduction in costs for deploying these functionalities.
Scope
Get your copy of this report @ http://www.reportsnreports.com/reports/187719-cloud-computing-in-pharmaceutical-research-and-development-virtualization-of-data-through-the-cloud-optimizes-next-generation-dna-sequencing-and-clinical-trials-data-management.html
Report Details:
Published: August 2012
No. of Pages: 39
Price: Single User License:US$ 3500 Corporate User License:US$10500
GBI Research analyses reveals that cloud computing has managed to change the invention, development, deployment updating and maintenance of information technology (IT) services. While the per-unit cost of computing has decreased due to the exponential increase in the power of modern machines, the cost of managing IT infrastructure has increased over the same time period. This is mainly due to the penetration of systems within the organization which has significantly increased the complexity of the entire infrastructure. Cloud computing promises to deliver existing as well as new functionalities of IT, coupled with a significant reduction in costs for deploying these functionalities.
Scope
- A brief technical understanding of cloud computing services
- Review of cloud computing service models, deployment models and role of major stakeholders
- Dedicated section on applications of cloud computing across the pharmaceutical industry value chain
- An understanding the benefits and restraints of cloud computing
- The report also covers information on the leading market players and the competitive landscape, including established companies, technology providers and innovative companies in the cloud computing space
- Develop business strategies by understanding the trends shaping and driving the use of cloud computing in healthcare
- Understand the potential areas of application across the value chain.
- Identify key services and applications which can be hosted on the cloud
- Identify the key players in the cloud computing space
